Coincident onset of multiple sclerosis and herpes simplex virus 1 encephalitis. a case report by Buscarinu, M. C. et al.
Multiple Sclerosis and
Demyelinating Disorders
Buscarinu et al. Multiple Sclerosis and Demyelinating Disorders  (2017) 2:6 
DOI 10.1186/s40893-017-0023-5CASE REPORT Open AccessCoincident onset of multiple sclerosis
and Herpes simplex virus 1 encephalitis:
a case report
M. C. Buscarinu1*, A. Fornasiero1, S. Romano1, M. Ferraldeschi3, R. Renié1, G. Trasimeni4, M. Salvetti1,2 and G. Ristori1Abstract
Background: Along with vitamin D, smoking, body mass index and others, Epstein Barr virus, other herpesviruses
and human endogenous retroviruses represent plausible environmental risk factors for multiple sclerosis. However,
it is difficult to obtain direct proof of their involvement in the etiology of this condition.
Case presentation: In order to contribute further evidence of the importance of these viruses, and speculate about
disease-relevant interactions between these agents and a predisposed genetic background of the host, we describe
the temporal association between multiple sclerosis onset and Herpes simplex 1-encephalitis in a female patient.
Conclusions: This case illustrates a possible relationship between HSV-1 encephalitis and multiple sclerosis. Bearing
in mind that association does not imply causation, some speculations about the etiology and pathophysiology of
the two diseases can be made. The hypothesis of a genetic background predisposing to HSV-1 encephalitis and to
immune-mediated demyelination is supported by the coincidence of the two conditions in this patient, along with
data from animal models and genetic studies.
Keywords: Multiple sclerosis, Environmental factors, HSV-1 encephalitisBackground
Heritable and nonheritable factors, and their interac-
tions, may be responsible for the autoimmune response
that leads to multiple sclerosis (MS) [1].
Genome-wide association studies are improving our
understanding of the heritable basis of the disease, most
probably involving subtle defects of the regulation of
transcription [2]. Though these studies are indeed ad-
vancing our knowledge, the nonheritable or “environ-
mental” component of the risk shows a slower progress.
Among the environmental risk factors, viruses are inten-
sively investigated as possible culprits [3]. Human en-
dogenous retroviruses such as MSRV have attracted
interest because of their capacity to hide by integrating
in the human DNA and then trigger immunological
mechanisms: a scenario that is compatible with the long
standing difficulties in detecting any infectious agent in* Correspondence: mariachiara.buscarinu@uniroma1.it
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pesviruses are sound candidates as well, because of
neurotropism and, in the case of Epsein Barr virus,
extraordinary ability to modulate the human immune
response.
In order to contribute further evidence of the import-
ance of these viruses, and speculate about disease-
relevant interactions between these agents and a predis-
posed genetic background of the host, we describe the
temporal association between MS onset and Herpes sim-
plex 1 (HSV)-encephalitis in a female patient.
Case Presentation
A 32 year-old woman presented acute dysesthesia in the
right face. Except for this symptom, her neurological
examination was unremarkable and neither the patient
nor her relatives could recall any previous neurological
episode. Her neurologist requested an MRI of the brain
and spinal cord that showed the simultaneous presence
of enhancing and nonenhancing white matter abnormal-
ities in MS-typical regions of the brain, compatible with
the diagnosis of a first episode of the disease (Fig. 1).le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Fig. 1 a Axial FLAIR MRI that highlights hyperintense left periventricular areas; b left periventricular and frontal subcortical; c right cerebellar peduncle
Fig. 2 Axial T2 image showing hyperintensity of the right temporal
lobe and right brainstem with less obvious contralateral alterations
Buscarinu et al. Multiple Sclerosis and Demyelinating Disorders  (2017) 2:6 Page 2 of 4She was then treated with methylprednisolone 1 g
intravenously for five days with a clear improvement of
the symptom. Ten days after the completion of the cor-
ticosteroid course, she presented fever, severe headache
and confusion. A brain CT scan was obtained, highlight-
ing a hypodense area that involved right temporal pole,
insula and hippocampus. She was then hospitalized and
her cerebrospinal fluid (CSF) tested positive for HSV-1
DNA. All other CSF tests were negative including: Cyto-
megalovirus, Varicella Zoster, Epstein Barr virus, John
Cunningham virus, enteroviruses, Toxoplasma, Crypto-
coccus, Mycobacterium tuberculosis and Treponema,
oligoclonal bands. With the exception of a positive test
for recent HSV-1 infection, all other serologies were
negative for recent infections including: Coxiella,
Coxsackie, Chlamydia pneumoniae, Borrelia burgdoferi,
Mycoplasma pneumoniae, echovirus and adenovirus.
Peripheral blood screening tests for autoimmune dis-
eases were negative.
Intravenous acyclovir was started but she rapidly
worsened (GCS: 4; E1, V1, M2) requiring orotracheal
intubation, tracheostomy, mechanical ventilation and
antiepileptic and antiedema therapy. Brain MRI ob-
tained 3 and 6 days after the CT scan showed the
involvement of the right hemisphere with diffuse
swelling and contralateral shift of the septum pelluci-
dum (Fig. 2).
After 22 days, HSV1 DNA in the CSF was negative
while a third MRI, contemporary to the CSF sampling,
showed a remarkable increase in the number and vol-
ume of lesions in MS-typical areas (some of them en-
hancing) and necrotic-malacic evolution of the herpetic
lesion (Fig. 3)
In view of the apparent flare of the “autoimmune” con-
dition, the patient was started on intravenous immuno-
globulins (IVIG) at 0.4gr/kg/daily for 5 days and
Methilprendisolone 40mg/daily for 15 days. She also
continued therapy with Valacyclovir 3g/ daily.
The MRI carried out as a control at the end of intra-
venous steroid therapy confirmed the necrotic-malacicevolution of the right temporal lesion, with a reduction
of the brainstem lesions and of the corpus callosum,
and with evidence of a C5 spinal cord area, compat-
ible with an inflammatory lesion. The enhancement of
lesions in MS-typical regions was not evident at this
point (Fig. 4).
She was transferred to a rehabilitation facility (GCS: 7)
and, after ten months, discharged home with a remark-
able improvement: left hemiparesis and left sensory syn-
drome but able to walk with assistance, short term
memory loss, fluctuating hyperactive state with mild agi-
tation. After additional six months of follow-up, she has
now slightly improved the strength of her left limbs. The
number and volume of areas in MS-typical regions is re-
duced though still increased with respect to the first
MRI and no new areas have appeared at brain and spinal
cord MRI follow-up (Fig. 5).
Fig. 3 Axial FLAIR showing the temporal encephalitis outcome
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This case illustrates a possible relationship between
HSV-1 encephalitis and MS.
Bearing in mind that association does not imply caus-
ation, some speculations about the etiology and patho-
physiology of the two diseases can be made.
To our knowledge, while the onset of MS after hemi-
thorax zoster, with intrathecal reactivation of HSV-1 and
HHV-6 has been reported [4] this is the first descriptionFig. 4 Cervical spinal cord sagittal image showing demyelinating
hyperintense areas at C4of a coincident onset of MS and HSV-1 encephalitis.
Other reports have provided laboratory evidence of the
intrathecal presence of HSV-1 at disease onset. This sup-
ports the possibility that, in an individual with a peculiar
genetic predisposition, this presence may turn into overt
HSV-1 encephalitis [5, 6]. However, other viruses such
as the John Cunningham (JC) virus have been described
as replicating in the cerebrospinal fluid during the first
symptoms of MS [7] though a coincident onset of MS
and progressive multifocal encaphalomyelitis have never
been described to our knowledge.
Most interestingly, the HSV-1 encephalitis develops in
individuals with inborn errors of immune response
genes that impair central nervous system-intrinsic inter-
feron alpha/beta production [8]. The therapeutic re-
sponse of persons with MS to interferon beta suggests
that a portion of the pathophysiology of the two diseases
may be shared. This possibility may be supported also by
the sharing of a predisposing gene, TRAF3, between the
two conditions (though this speculation has to be taken
with caution because the effects of the observed variants
may not be the same) [8, 9].
The role of a genetic predisposition emerges also from
studies in inbred mouse strains with variable degrees of
resistance to EAE/HSV [10]. In these models, the lip in-
oculation of the virus causes either no disease, or isolated
lesions, or a diffuse picture of demyelination, depending
on the genetic background of the mice. Interestingly, the
multifocal lesions in the susceptible mice were first ob-
served when the virus could no longer be isolated from
the CNS of the animals. This is in line with the diffuse
worsening of the bona-fide demyelinating lesions observed
in the patient, when the viral DNA became undetectable
in the CSF. Both observations are in harmony with an
immune-mediated process, triggered by the virus, in hosts
with a susceptible genetic background. Other sequences
of events cannot be excluded: the autoimmune damage
might have been present before the HSV-1 infection with
the latter being exacerbated by the corticosteroids course.
Nonetheless, the effects of corticosteroids in these patients
are debated, as clinical trials are ongoing to assess their
therapeutic effects in overt HSV-1 encephalitis. Also the
role played by the diffuse alteration of the blood brain bar-
rier (somehow resembling an acute disseminated enceph-
alomyelitis process, secondary to the HSV-1 infection)
remains unclear in the context of the whole process. A
longitudinal follow-up with, for example, IEF-overlay
technique with radiolabeled HSV glycoprotein B (gB), for
studying qualitative aspects of the HSV humoral immune
response [11, 12], would have been of use but was not per-
formed. More in general, as common pathophysiologies
emerge between MS and host immune response to vi-
ruses, tests for the detection of antiviral antibodies may
acquire more importance in the near future.
Fig. 5 Comparison of MRIs obtained at 4 months (a) and at 18 months after onset (b) showing a reduction of the areas in MS-typical regions
though the lesion load remains higher compared with the first MRI (Fig. 1)
Buscarinu et al. Multiple Sclerosis and Demyelinating Disorders  (2017) 2:6 Page 4 of 4All in all, the hypothesis of a genetic background pre-
disposing to HSV-1 encephalitis and to immune-
mediated demyelination is supported by the coincidence
of the two conditions in this patient, along with data
from animal models and genetic studies.
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